Relative Strength Alert For CytomX Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of CytomX Therapeutics Inc ( CTMX) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $10.11 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 59.1. A bullish investor could look at CTMX's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of CTMX shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

CytomX Therapeutics Inc 1 Year Performance Chart

Looking at the chart above, CTMX's low point in its 52 week range is $9.10 per share, with $24.68 as the 52 week high point — that compares with a last trade of $10.21.

If you liked this article you might like

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks Lower as Crude Slump Weighs on Energy Sector

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Soars on Bristol-Myers Partnership

CytomX Soars on Bristol-Myers Partnership